Thalidomide Versus Dexamethasone for the Treatment of Relapsed and/or Refractory Multiple Myeloma: Results From OPTIMUM, a Randomized Trial
Haematologica - Italy
doi 10.3324/haematol.2011.044271
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 1, 2011
Authors
Publisher
Ferrata Storti Foundation (Haematologica)